Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Expert Opinion on Drug Discovery|March 14, 2013
The potential for cancer combination therapy with multi-targeted, single-protein pharmaceuticalsJeffrey Way, Michael SuperChaos (Woodbury, N.Y.)|July 5, 2013
Dynamics simulations for engineering macromolecular interactionsAvi Robinson-Mosher, Tamar Shinar, Pamela A Silver, et al.Biophysical Journal|November 25, 2014
Designing cell-targeted therapeutic proteins reveals the interplay between domain connectivity and cell bindingAvi Robinson-Mosher, Jan-Hung Chen, Jeffrey Way, et al.Microbiology Resource Announcements|December 12, 2018
Escherichia coli NGF-1, a Genetically Tractable, Efficiently Colonizing Murine Gut IsolateMarika Ziesack, Michiel A P Karrenbelt, Johannes Bues, et al.Biorxiv : the Preprint Server for Biology|January 3, 2024
A long-acting prolactin to combat lactation insufficiencyKasia Kready, Kailyn Doiron, Katherine Redfield Chan, et al.Nature Biotechnology|November 30, 2010
Scalable gene synthesis by selective amplification of DNA pools from high-fidelity microchipsSriram Kosuri, Nikolai Eroshenko, Emily M Leproust, et al.Molecular Cell|November 18, 2017
Rational Design of Evolutionarily Stable Microbial Kill SwitchesFinn Stirling, Lisa Bitzan, Samuel O'Keefe, et al.Cell Reports|March 5, 2020
Synthetic Cassettes for pH-Mediated Sensing, Counting, and ContainmentFinn Stirling, Alexander Naydich, Juliet Bramante, et al.Journal of Mood and Anxiety Disorders|July 14, 2025
An examination of symptoms, function and quality of life as conjoint clinical outcome domains for treatment-resistant depressionCharles R Conway, A John Rush, Charles Gordon, et al.Brain Stimulation|December 19, 2024
Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trialA John Rush, Charles R Conway, Scott T Aaronson, et al.Pageof 2